Uterine prostaglandin production in ovine pregnancy

Effects of angiotensin II and indomethacin

R. R. Magness, C. R. Rosenfeld, D. J. Faucher, M. D. Mitchell

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

The ovine and human uteroplacental vascular beds are more refractory to angiotensin II (ANG II)-induced vasoconstriction than the systemic vasculature. ANG II increases in vitro prostacyclin (PGI2) production by uterine but not omental arteries from pregnant sheep. Thus vasodilator prostaglandins may account for this difference in vascular responsiveness. We measured uterine and systemic eicosanoid production and hemodynamic responses in pregnant sheep before and during intravenous ANG II (1.15 and 11.5 μg/min). ANG II caused dose-related increases in arterial pressure and systemic and uterine vascular resistance (P < 0.05). PGI2 metabolite (6- keto-PGF(1α)) in the uterine vein rose from 166 ± 70 (SE) to 223 ± 114 and 631 ± 323 pg/ml, respectively (P < 0.05), and arterial levels increased from 67 ± 24 to 145 ± 78 and 312 ± 173 pg/ml, respectively (P < 0.05). Basal uterine venoarterial differences of 6-keto-PGF(1α) were 99 ± 43 pg/ml and increased during 11.5 μg ANG II/min to 295 ± 181 pg/ml (P < 0.05) but not during 1.15 μg/min (64 ± 30 pg/ml). Responses were similar in gravid and nongravid uterine horns. Unilateral uterine prostaglandin inhibition with indomethacin did not alter basal uterine blood flow or systemic responses to ANG II (0.573-11.5 μg/min); however, ipsilateral uterine prostaglandin production fell and uterine vasoconstrictor responses increased (P < 0.05). During ovine pregnancy ANG II increases uterine PGI2 production. PGI2 appears in part to attenuate ANG II-induced uterine vasoconstriction.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume263
Issue number1 32-1
StatePublished - 1992

Fingerprint

Indomethacin
Angiotensin II
Prostaglandins
Sheep
Epoprostenol
Pregnancy
Prostaglandins F
Vasoconstriction
Blood Vessels
Eicosanoids
Vasoconstrictor Agents
Vasodilator Agents
Vascular Resistance
Veins
Arterial Pressure
Arteries
Hemodynamics

Keywords

  • cyclooxygenase inhibition
  • uterine blood flow
  • vascular reactivity

ASJC Scopus subject areas

  • Physiology

Cite this

Uterine prostaglandin production in ovine pregnancy : Effects of angiotensin II and indomethacin. / Magness, R. R.; Rosenfeld, C. R.; Faucher, D. J.; Mitchell, M. D.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 263, No. 1 32-1, 1992.

Research output: Contribution to journalArticle

@article{5510df6f8f8848e0807f08675b088460,
title = "Uterine prostaglandin production in ovine pregnancy: Effects of angiotensin II and indomethacin",
abstract = "The ovine and human uteroplacental vascular beds are more refractory to angiotensin II (ANG II)-induced vasoconstriction than the systemic vasculature. ANG II increases in vitro prostacyclin (PGI2) production by uterine but not omental arteries from pregnant sheep. Thus vasodilator prostaglandins may account for this difference in vascular responsiveness. We measured uterine and systemic eicosanoid production and hemodynamic responses in pregnant sheep before and during intravenous ANG II (1.15 and 11.5 μg/min). ANG II caused dose-related increases in arterial pressure and systemic and uterine vascular resistance (P < 0.05). PGI2 metabolite (6- keto-PGF(1α)) in the uterine vein rose from 166 ± 70 (SE) to 223 ± 114 and 631 ± 323 pg/ml, respectively (P < 0.05), and arterial levels increased from 67 ± 24 to 145 ± 78 and 312 ± 173 pg/ml, respectively (P < 0.05). Basal uterine venoarterial differences of 6-keto-PGF(1α) were 99 ± 43 pg/ml and increased during 11.5 μg ANG II/min to 295 ± 181 pg/ml (P < 0.05) but not during 1.15 μg/min (64 ± 30 pg/ml). Responses were similar in gravid and nongravid uterine horns. Unilateral uterine prostaglandin inhibition with indomethacin did not alter basal uterine blood flow or systemic responses to ANG II (0.573-11.5 μg/min); however, ipsilateral uterine prostaglandin production fell and uterine vasoconstrictor responses increased (P < 0.05). During ovine pregnancy ANG II increases uterine PGI2 production. PGI2 appears in part to attenuate ANG II-induced uterine vasoconstriction.",
keywords = "cyclooxygenase inhibition, uterine blood flow, vascular reactivity",
author = "Magness, {R. R.} and Rosenfeld, {C. R.} and Faucher, {D. J.} and Mitchell, {M. D.}",
year = "1992",
language = "English (US)",
volume = "263",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "1 32-1",

}

TY - JOUR

T1 - Uterine prostaglandin production in ovine pregnancy

T2 - Effects of angiotensin II and indomethacin

AU - Magness, R. R.

AU - Rosenfeld, C. R.

AU - Faucher, D. J.

AU - Mitchell, M. D.

PY - 1992

Y1 - 1992

N2 - The ovine and human uteroplacental vascular beds are more refractory to angiotensin II (ANG II)-induced vasoconstriction than the systemic vasculature. ANG II increases in vitro prostacyclin (PGI2) production by uterine but not omental arteries from pregnant sheep. Thus vasodilator prostaglandins may account for this difference in vascular responsiveness. We measured uterine and systemic eicosanoid production and hemodynamic responses in pregnant sheep before and during intravenous ANG II (1.15 and 11.5 μg/min). ANG II caused dose-related increases in arterial pressure and systemic and uterine vascular resistance (P < 0.05). PGI2 metabolite (6- keto-PGF(1α)) in the uterine vein rose from 166 ± 70 (SE) to 223 ± 114 and 631 ± 323 pg/ml, respectively (P < 0.05), and arterial levels increased from 67 ± 24 to 145 ± 78 and 312 ± 173 pg/ml, respectively (P < 0.05). Basal uterine venoarterial differences of 6-keto-PGF(1α) were 99 ± 43 pg/ml and increased during 11.5 μg ANG II/min to 295 ± 181 pg/ml (P < 0.05) but not during 1.15 μg/min (64 ± 30 pg/ml). Responses were similar in gravid and nongravid uterine horns. Unilateral uterine prostaglandin inhibition with indomethacin did not alter basal uterine blood flow or systemic responses to ANG II (0.573-11.5 μg/min); however, ipsilateral uterine prostaglandin production fell and uterine vasoconstrictor responses increased (P < 0.05). During ovine pregnancy ANG II increases uterine PGI2 production. PGI2 appears in part to attenuate ANG II-induced uterine vasoconstriction.

AB - The ovine and human uteroplacental vascular beds are more refractory to angiotensin II (ANG II)-induced vasoconstriction than the systemic vasculature. ANG II increases in vitro prostacyclin (PGI2) production by uterine but not omental arteries from pregnant sheep. Thus vasodilator prostaglandins may account for this difference in vascular responsiveness. We measured uterine and systemic eicosanoid production and hemodynamic responses in pregnant sheep before and during intravenous ANG II (1.15 and 11.5 μg/min). ANG II caused dose-related increases in arterial pressure and systemic and uterine vascular resistance (P < 0.05). PGI2 metabolite (6- keto-PGF(1α)) in the uterine vein rose from 166 ± 70 (SE) to 223 ± 114 and 631 ± 323 pg/ml, respectively (P < 0.05), and arterial levels increased from 67 ± 24 to 145 ± 78 and 312 ± 173 pg/ml, respectively (P < 0.05). Basal uterine venoarterial differences of 6-keto-PGF(1α) were 99 ± 43 pg/ml and increased during 11.5 μg ANG II/min to 295 ± 181 pg/ml (P < 0.05) but not during 1.15 μg/min (64 ± 30 pg/ml). Responses were similar in gravid and nongravid uterine horns. Unilateral uterine prostaglandin inhibition with indomethacin did not alter basal uterine blood flow or systemic responses to ANG II (0.573-11.5 μg/min); however, ipsilateral uterine prostaglandin production fell and uterine vasoconstrictor responses increased (P < 0.05). During ovine pregnancy ANG II increases uterine PGI2 production. PGI2 appears in part to attenuate ANG II-induced uterine vasoconstriction.

KW - cyclooxygenase inhibition

KW - uterine blood flow

KW - vascular reactivity

UR - http://www.scopus.com/inward/record.url?scp=0026725668&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026725668&partnerID=8YFLogxK

M3 - Article

VL - 263

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 1 32-1

ER -